Eye injuries that damage the cornea are usually irreversible and cause blindness. But a new clinical trial has repaired this ...

AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases.

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell ...

Chandigarh: The Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh is working towards establishing ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...

A recent Vanderbilt study has found a cure for sickle cell disease, a blood disorder where the body creates mutated red blood ...

Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals suffering from severe damage to the cornea.Cornea is the transparent, dome-shaped ...

Sebastien Beauzile, 21, has been cured of sickle cell anemia, according to his doctors at Cohen Children’s Medical Center.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...